CytoLog Questions and Answers
Answers provided by J. Michael Bentley
Q: What are the practical applications for Infopeptide supplementation?
A: At this time, the evaluation of Infopeptides is focused on twenty general categories of disease: Allergies, Arthritis, Benign Prostatic Hyperplasia, Cancer (adjunctive use only), Celiac Sprue, Crohn's disease, Diabetes type II, Hypertension, Lupus (discoid & systemic), Multiple Sclerosis, Perthes disease (active), Premenstrual Syndrome & Endometriosis, Prion diseases (Kuru & Creutzfeldt-Jakob syndrome), Psoriasis, Sjogren's syndrome, Spinal Muscular Atrophy, Thrombocytopenia (idiopathic & autoimmune), topical applications (burns, wounds, infections, insect bites, diaper rash & herpetic lesions), acute viral infections, and chronic viral infections.
Q: What are Infopeptides?
A: The word "Infopeptide" was invented and first used by the developer of Cytolog in 1993 as a way to describe his discovery. Infopeptides refers to a class of small proteins that are believed to act as informational media, advising and coordinating appropriate cellular functions in humans and other mammals. Information available at this time suggests that these peptides are produced in the ribosomes of cells, then circulate in the blood, and in the case of pregnant females, concentrate in the colostrum.
Q: How does the body use the Infopeptides?
A: The Infopeptides are absorbed through the oral mucosa and are not utilized through the digestive tract. For effective use, they have to be absorbed by live cells. This could also apply to an open wound. The cells seem to be able to clone or transfer the information to other cells in the body very fast. In infants, we have seen recovery from Viral Respiratory Infection and fever in about an hour which would be indicative of the information being shared extremely fast, especially given the total number of cells involved.